(+) マンザミンAの全合成
Tatsuya Toma1, Yoichi Kita, Tohru Fukuyama
1Graduate School of Pharmaceutical Sciences, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
Journal of the American Chemical Society
|July 29, 2010
まとめ
(+) - マンザミンAのための新しい合成経路が作成され,ストレートされた15本のリングを構築するための効率的な方法が特徴付けられました. このアプローチは,重要な分子特性を設置するための正確なステレオ化学制御を保証します.
科学分野:
- オーガニック・シンセシス オーガニック・シンセシス
- 薬用化学 薬用化学について
- 自然製品合成 自然製品の合成
背景:
- (+) -マンザミンAは,潜在的な生物学的活動を持つ複雑なアルカロイドです.
- 複雑な自然産物の効率的かつステレオ制御された合成は,有機化学における重要な課題です.
研究 の 目的:
- (+) -マンザミンA.の新しく効率的な合成経路を開発する.
- ステレオ制御による高度に圧迫された15本のリングシステムを構築する戦略を実証するためです.
主な方法:
- 光学的に活性なブテノリドを用いたステレオセレクティブのダイエルス・アルダー反応.
- 内分子ミツノブ反応で15個の環を構成する.
- [3,3]-窒素機能化のためのアルリルシアネートのシグマトロピク再配置.
- 敏感な機能群と互換性のある環閉転移である.
主要な成果:
- (+) -マンザミンA.への新しい合成経路の開発に成功しました.
- 効率的でステレオ制御された15組のリングの高圧構造です.
- ステレオセレクティブによる窒素機能の設置は,ステリア的に阻害された位置にします.
結論:
- 開発された合成経路は, (+) -マンザミンA.に効率的かつステレオ制御されたアクセスを提供します.
- 戦略は,正確なステレオ化学で複雑なポリサイクル構造を構築するための主要な反応を強調しています.
関連する概念動画
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic antagonists are called...
Preparation of 1° Amines: Gabriel Synthesis
Direct alkylation is not a suitable method for synthesizing amines because it produces polyalkylated products. Gabriel synthesis is the most preferred method to exclusively make primary amines. The method uses phthalimide, which contains a protected form of nitrogen that participates in alkylation only once to predominantly give primary amines.
Strong bases like NaOH or KOH deprotonate the phthalimide to form the corresponding anion, which acts as a nucleophile. Further, the anion attacks an...
Strong bases like NaOH or KOH deprotonate the phthalimide to form the corresponding anion, which acts as a nucleophile. Further, the anion attacks an...
Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Cholinergic Antagonists: Pharmacokinetics
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and the conjunctiva.


